Maresyl

Xylometazoline Hydrochloride, the active ingredient in Maresyl, is an alpha-adrenergic agonist presented as a nasal spray for nasal use. It relieves nasal congestion associated with the common cold and allergic rhinitis in adults and children over six years of age.

GNH USA supplies Maresyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maresyl, an alpha‑adrenergic nasal decongestant, is used to alleviate swelling of the nasal mucosa in several common upper‑respiratory conditions. - Common cold nasal congestion: reduces swelling of nasal passages and improves airflow. - Allergic rhinitis: eases blockage caused by allergic inflammation. - Acute sinusitis: helps clear nasal obstruction during early stages of sinus infection.

Maresyl may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal mucosa - Sneezing - Headache - Bitter or metallic taste - Transient epistaxis (nosebleed)

Serious or Rare Side Effects: - Hypertension or elevated blood pressure - Tachycardia or irregular heart rhythm - Severe nasal ulceration or perforation - Allergic reactions including rash, itching, or anaphylaxis - Rebound congestion with prolonged use beyond three days

Before using Maresyl, consider the following safety measures. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: use with caution; excretion in milk is not well defined. - Age restriction: not recommended for children under six years. - Concomitant sympathomimetic drugs: avoid combined use to prevent excessive vasoconstriction. - Prolonged use: limit to three consecutive days to reduce risk of rebound congestion. - Store at room temperature: keep in the original container, protect from moisture and direct heat.

Maresyl can interact with other medications that affect the cardiovascular or sympathetic systems.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may precipitate hypertensive crisis. - Other nasal decongestants: additive vasoconstrictive effects increase risk of ischemia. - Systemic sympathomimetics (e.g., pseudoephedrine): can amplify blood pressure elevation.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may reduce their effectiveness. - Beta‑blockers: may mask tachycardia caused by the spray. - Tricyclic antidepressants: monitor for changes in blood pressure and heart rate.